update on phase i/ii clinical trial for ornithine transcarbamylase (otc) deficiency using aav
Published 5 years ago • 1K plays • Length 27:06Download video MP4
Download video MP3
Similar videos
-
31:29
update on phase i/ii clinical trial of intracerebral administration of raav2/5hnaglu vector
-
6:10
phase 2 clinical trial update 1
-
16:25
long term safety of dtx301 for otc
-
26:23
patient issues and opportunities for fair access to gene-based therapies in rare disease
-
6:02
phase 2 clinical trial update 2
-
15:48
update on clinical trials
-
0:51
what are the results of the revive-2 trial?
-
1:51
phase ii extension trial of cnm-au8 in als
-
11:22
translating rnai for huntington’s disease - megan keiser
-
32:56
investigating the relationship between the host cell transcriptome and transfection efficiency
-
1:39
new clinical trial results in cardiac and peripheral nerve amyloidosis
-
14:43
progress report ii - vivien unger
-
1:44
protocol selection
-
3:34
dose-escalation results from phase ib/iia trial of azd4573 acalabrutinib in r/r dlbcl
-
2:38
welcome to asgct: who we are and what we do
-
1:26:41
part 2: als canada webinar series: update on als clinical trials
-
1:34
all of us establishes genetic counseling resource | news & updates
-
18:43
development and application of an immunization validation engine utilizing r